Description
TINA: Talking about Infection and Neutropenia Awareness is an app to educate patients and healthcare providers about preventing infection during chemo.
For cancer patients: engage in an interactive learning experience that prepares you and your caregivers to reduce their risk of infection during chemotherapy, and know what to do if you notice signs of infection. Play the role of a virtual patient and meet Tina, a virtual oncologist, who answers your questions about neutropenia and preventing infection.
For healthcare providers: practice sharing information about neutropenia with your patients through an interactive conversation. Play the role of Tina, a virtual oncologist, and learn how to quickly and effectively have this conversation to achieve better adherence and outcomes. Then meet a virtual patient and practice a realistic conversation.
* FEATURES
Engage in a conversation about neutropenia, from a patient or a healthcare provider perspective
Learn about neutropenia and reducing risk of infection during treatment (for patients), and how to effectively have conversations with a cancer patient about infection during treatment (for healthcare professionals)
Access a helpful list of resources: staying safe during treatment (for patients), and more information about effectively talking with patients and useful materials to provide for them (for healthcare professionals)
Acknowledgements:
This program and its content were developed as part of the Preventing Infections in Cancer Patients (PICP) program. PICP is a comprehensive initiative led by CDC and the CDC Foundation to reduce infections in cancer patients.
The simulation was developed by Kognito in collaboration with the CDC Foundation. The simulation is powered by the Kognito proprietary simulation platform and methodology (“Kognito IP”). All rights in Kognito IP reserved. © 2018 Kognito Solutions, LLC.
This simulation was made possible through a CDC Foundation partnership with, and funding from, Amgen. As part of the partnership, the CDC Foundation considered oncology expertise provided by Amgen. Learn more about the program at www.cdcfoundation.org/preventcancerinfections. Learn more about CDC's work to prevent infections in cancer patients at www.cdc.gov/cancer/preventinfections.
Hide
Show More...
For cancer patients: engage in an interactive learning experience that prepares you and your caregivers to reduce their risk of infection during chemotherapy, and know what to do if you notice signs of infection. Play the role of a virtual patient and meet Tina, a virtual oncologist, who answers your questions about neutropenia and preventing infection.
For healthcare providers: practice sharing information about neutropenia with your patients through an interactive conversation. Play the role of Tina, a virtual oncologist, and learn how to quickly and effectively have this conversation to achieve better adherence and outcomes. Then meet a virtual patient and practice a realistic conversation.
* FEATURES
Engage in a conversation about neutropenia, from a patient or a healthcare provider perspective
Learn about neutropenia and reducing risk of infection during treatment (for patients), and how to effectively have conversations with a cancer patient about infection during treatment (for healthcare professionals)
Access a helpful list of resources: staying safe during treatment (for patients), and more information about effectively talking with patients and useful materials to provide for them (for healthcare professionals)
Acknowledgements:
This program and its content were developed as part of the Preventing Infections in Cancer Patients (PICP) program. PICP is a comprehensive initiative led by CDC and the CDC Foundation to reduce infections in cancer patients.
The simulation was developed by Kognito in collaboration with the CDC Foundation. The simulation is powered by the Kognito proprietary simulation platform and methodology (“Kognito IP”). All rights in Kognito IP reserved. © 2018 Kognito Solutions, LLC.
This simulation was made possible through a CDC Foundation partnership with, and funding from, Amgen. As part of the partnership, the CDC Foundation considered oncology expertise provided by Amgen. Learn more about the program at www.cdcfoundation.org/preventcancerinfections. Learn more about CDC's work to prevent infections in cancer patients at www.cdc.gov/cancer/preventinfections.
Screenshots
T.I.N.A. FAQ
-
Is T.I.N.A. free?
Yes, T.I.N.A. is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is T.I.N.A. legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does T.I.N.A. cost?
T.I.N.A. is free.
-
What is T.I.N.A. revenue?
To get estimated revenue of T.I.N.A. app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Canada yet.
Ratings History
T.I.N.A. Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
T.I.N.A. Installs
Last 30 days
T.I.N.A. Revenue
Last 30 daysT.I.N.A. Revenue and Downloads
Gain valuable insights into T.I.N.A. performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- Kognito Interactive
- Languages
- English
- Recent release
- 2 (2 years ago )
- Released on
- Sep 7, 2018 (6 years ago )
- Also available in
- Philippines , India , Italy , Japan , South Korea , Lebanon , Latvia , Mexico , Malaysia , Nigeria , Norway , New Zealand , Peru , Israel , Pakistan , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Thailand , Ukraine , United States , South Africa , Colombia , Argentina , Austria , Australia , Azerbaijan , Belgium , Brunei , Brazil , Belarus , Canada , Switzerland , Chile , China , United Arab Emirates , Czechia , Germany , Denmark , Algeria , Ecuador , Egypt , Spain , United Kingdom , Greece , Indonesia , Ireland
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.